491 related articles for article (PubMed ID: 29229998)
1. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.
Connolly NMC; Theurey P; Adam-Vizi V; Bazan NG; Bernardi P; Bolaños JP; Culmsee C; Dawson VL; Deshmukh M; Duchen MR; Düssmann H; Fiskum G; Galindo MF; Hardingham GE; Hardwick JM; Jekabsons MB; Jonas EA; Jordán J; Lipton SA; Manfredi G; Mattson MP; McLaughlin B; Methner A; Murphy AN; Murphy MP; Nicholls DG; Polster BM; Pozzan T; Rizzuto R; Satrústegui J; Slack RS; Swanson RA; Swerdlow RH; Will Y; Ying Z; Joselin A; Gioran A; Moreira Pinho C; Watters O; Salvucci M; Llorente-Folch I; Park DS; Bano D; Ankarcrona M; Pizzo P; Prehn JHM
Cell Death Differ; 2018 Mar; 25(3):542-572. PubMed ID: 29229998
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.
Catanesi M; d'Angelo M; Tupone MG; Benedetti E; Giordano A; Castelli V; Cimini A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825273
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
Wu Y; Chen M; Jiang J
Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dynamics, a key executioner in neurodegenerative diseases.
Panchal K; Tiwari AK
Mitochondrion; 2019 Jul; 47():151-173. PubMed ID: 30408594
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.
Jadiya P; Garbincius JF; Elrod JW
Acta Neuropathol Commun; 2021 Jul; 9(1):124. PubMed ID: 34233766
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species: stuck in the middle of neurodegeneration.
Patten DA; Germain M; Kelly MA; Slack RS
J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases.
Johnson J; Mercado-Ayon E; Mercado-Ayon Y; Dong YN; Halawani S; Ngaba L; Lynch DR
Arch Biochem Biophys; 2021 May; 702():108698. PubMed ID: 33259796
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models.
Trombetta-Lima M; Sabogal-Guáqueta AM; Dolga AM
Cell Calcium; 2021 Mar; 94():102362. PubMed ID: 33540322
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria as a therapeutic target for aging and neurodegenerative diseases.
Reddy PH; Reddy TP
Curr Alzheimer Res; 2011 Jun; 8(4):393-409. PubMed ID: 21470101
[TBL] [Abstract][Full Text] [Related]
10. Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases.
Gubellini P; Picconi B; Di Filippo M; Calabresi P
Biochim Biophys Acta; 2010 Jan; 1802(1):151-61. PubMed ID: 19683569
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer.
Palmer CS; Anderson AJ; Stojanovski D
FEBS Lett; 2021 Apr; 595(8):1107-1131. PubMed ID: 33314127
[TBL] [Abstract][Full Text] [Related]
12. Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases.
Qi Z; Huang Z; Xie F; Chen L
J Cell Physiol; 2019 Jul; 234(7):10032-10046. PubMed ID: 30515821
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective.
Mulica P; Grünewald A; Pereira SL
Front Endocrinol (Lausanne); 2021; 12():668517. PubMed ID: 34025580
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and Mitochondria: Targets in Neurodegenerative Disorders.
Kumar A; Dhawan A; Kadam A; Shinde A
CNS Neurol Disord Drug Targets; 2018; 17(9):696-705. PubMed ID: 30113005
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in neurodegenerative diseases.
Johri A; Beal MF
J Pharmacol Exp Ther; 2012 Sep; 342(3):619-30. PubMed ID: 22700435
[TBL] [Abstract][Full Text] [Related]
17. New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.
Wilkins HM; Morris JK
Curr Pharm Des; 2017; 23(5):731-752. PubMed ID: 28034353
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
